Filing Details
- Accession Number:
- 0001104659-23-007094
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-26 17:49:09
- Reporting Period:
- 2023-01-25
- Accepted Time:
- 2023-01-26 17:49:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1788028 | Jasper Therapeutics Inc. | JSPR | American Depositary Receipts (8880) | V8 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
889131 | Ltd Holding Roche | Grenzacherstrasse 124, 4070 Basel V8 CH-4070 | No | No | Yes | No | |
1053942 | Ltd Finance Roche | Grenzacherstrasse 124, 4070 Basel V8 CH-4070 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Voting Common Stock | Disposition | 2023-01-25 | 75,000 | $1.89 | 4,549,606 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
Footnotes
- Represents shares held by Roche Finance Ltd ("Roche Finance"). Roche Finance is a wholly owned subsidiary of Roche Holding Ltd ("Roche Holding"), a Swiss corporation whose shares are traded on the SIX Swiss Exchange. Roche Holding is the indirect beneficial owner of these securities of the Issuer. This Form 4 shall not be deemed an admission that any reporting person or other person is a beneficial owner of any securities of the Issuer for any purpose, other than the securities reported in this Form 4.